Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells

Xiao-Ping Chen1, Shou Liu, Wen-Xin Tang

  • 1Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Technology, Wuhan, 430074, China.

Insights

Nuclear thioredoxin-1 (Trx-1) protects breast cancer cells from cisplatin-induced apoptosis. Increased nuclear Trx-1 is linked to cisplatin resistance, likely by upregulating the p53 gene.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Thioredoxin-1 (Trx-1) levels influence sensitivity to cisplatin.
  • Subcellular localization of Trx-1 is critical for its function.
  • The role of nuclear Trx-1 in breast cancer cell response to cisplatin is not fully understood.

Purpose of the Study:

  • To investigate the association between nuclear Trx-1 and cisplatin-mediated apoptosis in MCF-7 breast cancer cells.
  • To determine if nuclear Trx-1 contributes to cisplatin resistance.

Main Methods:

  • MCF-7 cells were transfected with Trx-1 cDNA.
  • Total and nuclear Trx-1 levels were assessed.
  • Cisplatin-induced apoptosis was measured.
  • mRNA levels of p53 were analyzed.

Main Results:

  • Increased total Trx-1 without altered nuclear Trx-1 did not affect cisplatin-induced apoptosis.
  • Elevated nuclear Trx-1, independent of total Trx-1, protected cells from cisplatin-induced apoptosis.
  • High nuclear Trx-1 correlated with cisplatin resistance in resistant cell lines.
  • Nuclear Trx-1 levels were closely correlated with p53 mRNA levels.

Conclusions:

  • Nuclear Trx-1 plays a crucial role in resisting cisplatin-induced apoptosis in MCF-7 cells.
  • Nuclear Trx-1 likely confers cisplatin resistance by upregulating the anti-apoptotic gene p53.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.